Search Results 1531-1540 of 11391 for anti-TNF drugs

1. Etigilimab And Nivolumab In Subjects With Locally Advanced Or Metastatic Tumors - Mayo Clinic

   ... anti-PD1/PDL-1 therapy. Exclusion Criteria: Concurrent active malignancy. Major surgery within 4 weeks of treatment. Subjects with active, known or ...

2. Study identifies patients who would benefit from redifferentiation therapy for thyroid cancer - Mayo Clinic

   A study published in the January 2024 issue of Thyroid provides insights into which patients benefit most from radioactive redifferentiation therapy and ...

3. A Study to Evaluate the Safety, Pharmacokinetics and Biodistribution of an Imaging Agent, 18F-OP-801 (18F Hydroxyl Dendrimer) in Patients With Amyotrophic Lateral Sclerosis (ALS) and Healthy Volunteers (HV) - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... anti-NMO \[aquaporin-4\] antibodies or anti-MOG antibodies)

4. Clinical trials - Oncology (Medical)

   Drugs & Supplements · Healthy Lifestyle · Mayo ... (Z)-endoxifen belongs to a group of drugs called ... anti-CTLA-4 +/- anti-PD-1/PD-L1, and (2) anti-PD ...

5. Multiple Sclerosis Clinical Trials

   The purpose of this study is to determine whether aspirin is effective for treatment of fatigue caused by multiple sclerosis (MS). Best Available Therapy Versus ...

6. Transplant Disorder Clinical Trials - Mayo Clinic Research

   The purpose of this study is to investigate whether clazakizumab (an anti-interleukin (IL)-6 monoclonal antibody (mAb)) may be beneficial for the treatment of ...

7. Testing The Effects Of Novel Therapeutics For Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) - Mayo Clinic

   This phase II MyeloMATCH treatment trial tests whether the standard approach of cytarabine and daunorubicin in comparison to the following experimental regimens ...

8. Viral Hepatitis Clinical Trials - Mayo Clinic Research

   The purpose of this study is to measure the rates of continuing viral presence, following anti-viral therapy with combined Peg-Interferon and Ribavirin in ...

9. Tacrolimus (topical route) - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

10. Elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide (oral route) - Side effects & dosage - Mayo Clinic

    ... drugs may be the best treatment for you. ... These reactions are more common if you are female, obese, or have been taking anti-HIV medicines for a long time.